A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease

Tobias Skillbäck, Niklas Mattsson, Karl F. Hansson, Ekaterina Mirgorodskaya, Rahil Dahlén, Wiesje van der Flier, Philip Scheltens, Floor Duits, Oskar Hansson, Charlotte Teunissen, Kaj Blennow, Henrik Zetterberg, Johan Gobom

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology